Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

CHICAGO--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading cloud-based human capital and technology-enabled services provider, today announced its top 5 placements in Sapient Insights Group's 28th Annual HR Systems Survey Report. This prestigious report highlights the top-performing HR technology solutions based on vendor and customer feedback. Alight earned top 5 rankings in User Experience and Vendor Satisfaction in the enterprise category, underscoring its strength in delivering technolo.

Coughlin Brings Nearly 30 Years of Financial Operational Experience Tom Barry to Step Down, Effective December 31 NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Sirius XM Holdings Inc. (NASDAQ: SIRI) today announced that it has appointed Zac Coughlin as the Company's next Chief Financial Officer, effective January 1, 2026. Coughlin will succeed Tom Barry who is stepping down as SiriusXM's CFO.

Tech slumps ahead of Nvidia earnings, but ETFs like KNCT, LEGR and XT have shown upside in recent weeks, with low valuations and rising momentum.

BERKELEY, Calif. and MAINZ, Germany, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V.

YieldMax GOOGL Option Income Strategy ETF (GOOY) is upgraded to a buy, ideal for investors bullish on Alphabet but expecting choppy upside. GOOY offers a high starting dividend yield of ~33.36% with weekly payouts, but distributions are variable and may not suit those seeking consistency. GOOY's synthetic option strategy generates income but leads to NAV decay and underperforms GOOG during strong bull markets.

Shares of Dutch Bros (NYSE:BROS) lost 5.99% over the past month after losing 6.42% the month prior.

Shares of NVIDIA Corp. (NASDAQ:NVDA) lost 4.32% over the past five trading sessions after losing 1.87%% the five prior.

Shares of Rivian Automotive (NASDAQ:RIVN) lost 9.21% over the past five trading sessions after gaining 26.87%% the five prior.

Toyota Motor on Tuesday said it will invest $912 million in U.S. manufacturing plants in five southern states. The investment follows the Japanese automaker last week confirming plans announced by President Donald Trump to invest up to $10 billion in the U.S. by 2030.

Netflix has been building out its original content library and now has enough popular programming to warrant a major investment in the retail space. The streaming giant has partnered with toy companies like Hasbro, Mattel and Jazwares to bring merchandise to store shelves across a broad range of segments.

Intuit is paying OpenAI more than $100M a year for access to its artificial intelligence models that will power AI agents across TurboTax, QuickBooks, Credit Karma and Mailchimp. ChatGPT users will be able to link their Intuit accounts and act on personalized tax and financial insights inside ChatGPT.

MINNEAPOLIS and TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today released The Retirement Divide , a new report that shows deep and growing disparities in how American workers are saving for retirement. The research examines trends in retirement savings rates, employee and employer contributions, participation in employer and individual retirement plans, and loan use among the full-time U.S. workforce from 2021 to 2024.

BEIJING, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced that its Board of Directors (the “Board”) has formed a special committee (the “Special Committee”) to, among other things, evaluate (i) the preliminary non-binding proposal letter, dated November 1, 2025, that it received from Zhongsheng Dingxin Investment Fund Management (Beijing) Co., Ltd., an existing shareholder of the Company, proposing to acquire all of the outstanding Class A ordinary shares of the Company, par value $0.001 per share (“Class A Shares”) …

POWAY, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Disguise, Inc., the global costume division of leading toy and consumer products company JAKKS Pacific, Inc. (NASDAQ: JAKK), today announced that it has been ranked the #1 costume manufacturer in the U.S. for year-to-date (YTD) 2025, according to Circana (Source: Circana, LLC, Retail Tracking Service, Costumes Supercategory, Dollars Adjusted, Jan–Sept 2025 and Jan 2023–Dec 2024). This marks the third consecutive year Disguise has held the top spot, after previously rising from #2 in 2022 (Source: Circana, LLC, Retail Tracking Service, Costumes Supercategory, Dollars Adjusted, Jan–Sept 2025 vs. Jan–Dec 2022).

The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics of NS002 against EpiPen

CARMEL, Ind., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present and participate in the 37th Annual Piper Sandler Healthcare Conference being held on December 2-4.

SCHMID Group is proud to announce that its InfinityLine L+ has been awarded the Innovation Award productronica 2025 in the category Cluster PCB & EMS.

Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentations at the upcoming 18th Clinical Trials on Alzheimer's Disease conference (CTAD), in San Diego, CA on December 1-4, 2025.

GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN® (naloxone HCl) Nasal Spray as the first FDA-approved nasal naloxone spray for emergency treatment of opioid overdose.